• Aucoin, M., LaChance, L., Naidoo, U., Remy, D., Shekdar, T., Sayar, N., ... & Cooley, K. (2021). Diet and anxiety: A scoping review. Nutrients, 13(12), 4418.

• Gonzalez, M. J., & Miranda-Massari, J. R. (2014). Diet and stress. Psychiatric Clinics, 37(4), 579-589.

• Kris-Etherton, P. M., Petersen, K. S., Hibbeln, J. R., Hurley, D., Kolick, V., Peoples, S., ... & Woodward-Lopez, G. (2021). Nutrition and behavioral health disorders: depression and anxiety. Nutrition reviews, 79(3), 247-260.

• Sadeghi, O., Keshteli, A. H., Afshar, H., Esmaillzadeh, A., & Adibi, P. (2021). Adherence to Mediterranean dietary pattern is inversely associated with depression, anxiety and psychological distress. Nutritional neuroscience, 24(4), 248-259.

• Shively, C. A., Appt, S. E., Chen, H., Day, S. M., Frye, B. M., Shaltout, H. A., ... & Register, T. C. (2020). Mediterranean diet, stress resilience, and aging in nonhuman primates. Neurobiology of Stress, 13, 100254.

• Soltani, H., Keim, N. L., & Laugero, K. D. (2018). Diet quality for sodium and vegetables mediate effects of whole food diets on 8-week changes in stress load. Nutrients, 10(11), 1606.

• Taylor, A. M., & Holscher, H. D. (2020). A review of dietary and microbial connections to depression, anxiety, and stress. Nutritional neuroscience, 23(3), 237-250.

• Kaplan, B. J., Rucklidge, J. J., Romijn, A. R., & Dolph, M. (2015). A randomised trial of nutrient supplements to minimise psychological stress after a natural disaster. Psychiatry research, 228(3), 373-379.

• Lewis, J. E., Tiozzo, E., Melillo, A. B., Leonard, S., Chen, L., Mendez, A., ... & Konefal, J. (2013). The effect of methylated vitamin B complex on depressive and anxiety symptoms and quality of life in adults with depression. International Scholarly Research Notices, 2013.

• Mahdavifar, B., Hosseinzadeh, M., Salehi-Abargouei, A., Mirzaei, M., & Vafa, M. (2021). Dietary intake of B vitamins and their association with depression, anxiety, and stress symptoms: A cross-sectional, population-based survey. Journal of Affective Disorders, 288, 92-98.

• Young, L. M., Pipingas, A., White, D. J., Gauci, S., & Scholey, A. (2019). A systematic review and meta-analysis of B vitamin supplementation on depressive symptoms, anxiety, and stress: Effects on healthy and ‘at-risk’individuals. Nutrients, 11(9), 2232.

• McCabe, D., Lisy, K., Lockwood, C., & Colbeck, M. (2017). The impact of essential fatty acid, B vitamins, vitamin C, magnesium and zinc supplementation on stress levels in women: a systematic review. JBI Evidence Synthesis, 15(2), 402-453.

• Moritz, B., Schmitz, A. E., Rodrigues, A. L. S., Dafre, A. L., & Cunha, M. P. (2020). The role of vitamin C in stress-related disorders. The Journal of Nutritional Biochemistry, 85, 108459.

• Ribeiro, C. (2015). Effects of oral vitamin C supplementation on anxiety in students: a doubleblind, randomized, placebo-controlled trial. Pakistan journal of biological sciences, 18(1), 11-18.

• Sim, M., Hong, S., Jung, S., Kim, J. S., Goo, Y. T., Chun, W. Y., & Shin, D. M. (2022). Vitamin C supplementation promotes mental vitality in healthy young adults: results from a cross-sectional analysis and a randomized, double-blind, placebo-controlled trial. European journal of nutrition, 61(1), 447-459.

• Suh, S. Y., Bae, W. K., Ahn, H. Y., Choi, S. E., Jung, G. C., & Yeom, C. H. (2012). Intravenous vitamin C administration reduces fatigue in office workers: a double-blind randomized controlled trial. Nutrition journal, 11(1), 1-7.

• Bicikova, M., Duskova, M., Vitku, J., Kalvachová, B., Ripova, D., Mohr, P., & Stárka, L. (2015). Vitamin D in anxiety and affective disorders. Physiological research, 64, S101.

• Casseb, G. A., Kaster, M. P., & Rodrigues, A. L. S. (2019). Potential role of vitamin D for the management of depression and anxiety. CNS drugs, 33(7), 619-637.

• Parker, G. B., Brotchie, H., & Graham, R. K. (2017). Vitamin D and depression. Journal of affective disorders, 208, 56-61.

• Jeong, H., Oh, J. W., Son, N. H., & Lee, S. (2023). Age and Sex Differences in the Association between Serum Vitamin E Levels and Depressive Symptoms: Korea National Health and Nutrition Examination Survey. Nutrients, 15(8), 1915.

• Lee, A. R. Y. B., Tariq, A., Lau, G., Tok, N. W. K., Tam, W. W. S., & Ho, C. S. H. (2022). Vitamin E, alpha-tocopherol, and its effects on depression and anxiety: a systematic review and meta-analysis. Nutrients, 14(3), 656.

• Islam, M. R., Ali, S., Karmoker, J. R., Kadir, M. F., Ahmed, M. U., Nahar, Z., ... & Islam, M. S. (2020). Evaluation of serum amino acids and non-enzymatic antioxidants in drug-naïve first-episode major depressive disorder. BMC psychiatry, 20, 1-8.

• Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011). A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35(3), 676-692.

• Ding, J., & Zhang, Y. (2022). Associations of dietary vitamin C and E intake with depression. A meta-analysis of observational studies. Frontiers in Nutrition, 9,

• Abbasi, B., Kimiagar, M., Sadeghniiat, K., Shirazi, M. M., Hedayati, M., & Rashidkhani, B. (2012). The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences, 17(12), 1161.

• Afsharfar, M., Shahraki, M., Shakiba, M., Asbaghi, O., & Dashipour, A. (2021). The effects of magnesium supplementation on serum level of brain derived neurotrophic factor (BDNF) and depression status in patients with depression. Clinical nutrition ESPEN, 42, 381-386.

• Botturi, A., Ciappolino, V., Delvecchio, G., Boscutti, A., Viscardi, B., & Brambilla, P. (2020). The role and the effect of magnesium in mental disorders: a systematic review. Nutrients, 12(6), 1661.

• Chiu, H. Y., Yeh, T. H., Yin-Cheng, H., & Pin-Yuan, C. (2016). Effects of intravenous and oral magnesium on reducing migraine: a meta-analysis of randomized controlled trials. Pain physician, 19(1), E97.

• Nazarinasab, M., Behrouzian, F., Abdi, L., Moghaddam, A. A. S., & Sadeghi, S. (2022). Investigating the effect of magnesium supplement in patients with major depressive disorder under selective serotonin reuptake inhibitor treatment. Journal of Family Medicine and Primary Care, 11(12), 7800.

• Pickering, G., Mazur, A., Trousselard, M., Bienkowski, P., Yaltsewa, N., Amessou, M., ... & Pouteau, E. (2020). Magnesium status and stress: the vicious circle concept revisited. Nutrients, 12(12), 3672.

• Sawada, T., & Yokoi, K. (2010). Effect of zinc supplementation on mood states in young women: a pilot study. European journal of clinical nutrition, 64(3), 331-333.

• Yosaee, S., Clark, C. C., Keshtkaran, Z., Ashourpour, M., Keshani, P., & Soltani, S. (2020). Zinc in depression: From development to treatment: A comparative/dose response meta-analysis of observational studies and randomized controlled trials. General Hospital Psychiatry.

• Arab, A., Rafie, N., Askari, G., & Taghiabadi, M. (2020). Beneficial role of calcium in premenstrual syndrome: a systematic review of current literature. International journal of preventive medicine, 11.

• Lopresti, A. L. (2020). The effects of psychological and environmental stress on micronutrient concentrations in the body: a review of the evidence. Advances in Nutrition, 11(1), 103-112.

• Berthou, C., Iliou, J. P., & Barba, D. (2021). Iron, neuro-bioavailability and depression. EJHaem, 3(1), 263–275. https://doi.org/10.1002/jha2.321

• Favrat, B., Balck, K., Breymann, C., Hedenus, M., Keller, T., Mezzacasa, A., & Gasche, C. (2014). Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women–PREFER a randomized, placebo-controlled study. PloS one, 9(4), e94217.

• Kapoor, M. P., Sugita, M., Kawaguchi, M., Timm, D., Kawamura, A., Abe, A., & Okubo, T. (2023). Influence of iron supplementation on fatigue, mood states and sweating profiles of healthy non-anemic athletes during a training exercise: A double-blind, randomized, placebo-controlled, parallel-group study. Contemporary Clinical Trials Communications, 32, 101084.

• Totten, M. S., Davenport, T. S., Edwards, L. F., & Howell, J. M. (2023). Trace Minerals and Anxiety: A Review of Zinc, Copper, Iron, and Selenium. Dietetics, 2(1), 83-103.

• Trotti, L. M., & Becker, L. A. (2019). Iron for the treatment of restless legs syndrome. Cochrane Database of Systematic Reviews, (1).

• Vaucher, P., Druais, P. L., Waldvogel, S., & Favrat, B. (2012). Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. Cmaj, 184(11), 1247-1254.

• Woods, A., Garvican-Lewis, L. A., Saunders, P. U., Lovell, G., Hughes, D., Fazakerley, R., ... & Thompson, K. G. (2014). Four weeks of IV iron supplementation reduces perceived fatigue and mood disturbance in distance runners. PloS one, 9(9), e108042.

• Rajkumar, R. P. (2022). Selenium and Its Compounds in the Treatment of Anxiety and Related Disorders: A Scoping Review of Translational and Clinical Research. Future Pharmacology, 2(4), 608-624.

• Totten, M. S., Davenport, T. S., Edwards, L. F., & Howell, J. M. (2023). Trace Minerals and Anxiety: A Review of Zinc, Copper, Iron, and Selenium. Dietetics, 2(1), 83-103.

• Turan, E., & Karaaslan, O. (2020). The relationship between iodine and selenium levels with anxiety and depression in patients with euthyroid nodular goiter. Oman Medical Journal, 35(4), e161.

• Kostoglou-Athanassiou, I., & Ntalles, K. (2010). Hypothyroidism-new aspects of an old disease. Hippokratia, 14(2), 82.

• Chiovato, L., Magri, F., & Carlé, A. (2019). Hypothyroidism in context: where we’ve been and where we’re going. Advances in therapy, 36, 47-58.

• Subklinisk hypotyreose. (n.d.). NHI.no. Retrieved August 18, 2023, from https://nhi.no/sykdommer/hormoner-og-naring/skjoldkjertelsykdommer/subklinisk-hypotyreose/?page=3

• Henjum, S., Abel, M. H., Meltzer, H. M., Dahl, L., Alexander, J., Torheim, L. E., & Brantsæter, A. L. (2019). Er inntaket av jod i befolkningen tilstrekkelig? Tidsskrift for Den Norske Legeforening. https://doi.org/10.4045/tidsskr.18.0319

• Memon A, Rogers I, Fitzsimmons SMDD, Carter B, Strawbridge R, Hidalgo-Mazzei D, Young AH. Association between naturally occurring lithium in drinking water and suicide rates: systematic review and meta-analysis of ecological studies. Br J Psychiatry. 2020 Dec;217(6):667-678.

• Schrauzer, G. N., & de Vroey, E. (1994). Effects of nutritional lithium supplementation on mood: a placebo-controlled study with former drug users. Biological trace element research, 40, 89-101.

• Marshall, T. M. (2015). Lithium as a nutrient. Journal of American Physicians and Surgeons, 20(4), 104-109.

• Izumi, T., Kanehisa, M., Terao, T., Shiotsuki, I., Shirahama, M., Satoh, M., ... & Matsukawa, T. (2022). Naturally absorbed lithium may prevent suicide attempts and deliberate self-harm while eicosapentaenoic acid may prevent deliberate self-harm and arachidonic acid may be a risk factor for deliberate self-harm: The updated different findings in new analyses. Frontiers in psychiatry, 13, 1083739.

• Jahangard, L., Hedayati, M., Abbasalipourkabir, R., Haghighi, M., Ahmadpanah, M., Faryadras, M., ... & Brand, S. (2019). Omega-3-polyunsatured fatty acids (O3PUFAs), compared to placebo, reduced symptoms of occupational burnout and lowered morning cortisol secretion. Psychoneuroendocrinology, 109, 104384.

• Liao, Y., Xie, B., Zhang, H., He, Q., Guo, L., Subramanieapillai, M., ... & McIntyre, R. S. (2019). Efficacy of omega-3 PUFAs in depression: a meta-analysis. Translational psychiatry, 9(1), 1-9.

• Polokowski, A. R., Shakil, H., Carmichael, C. L., & Reigada, L. C. (2020). Omega-3 fatty acids and anxiety: A systematic review of the possible mechanisms at play. Nutritional Neuroscience, 23(7), 494-504.

• Su, K. P., Tseng, P. T., Lin, P. Y., Okubo, R., Chen, T. Y., Chen, Y. W., & Matsuoka, Y. J. (2018). Association of use of omega-3 polyunsaturated fatty acids with changes in severity of anxiety symptoms: a systematic review and meta-analysis. JAMA network open, 1(5), e182327-e182327.

• Javelle, F., Lampit, A., Bloch, W., Häussermann, P., Johnson, S. L., & Zimmer, P. (2020). Effects of 5-hydroxytryptophan on distinct types of depression: A systematic review and meta-analysis. Nutrition reviews, 78(1), 77-88.

• Kikuchi, A. M., Tanabe, A., & Iwahori, Y. (2021). A systematic review of the effect of L-tryptophan supplementation on mood and emotional functioning. Journal of dietary supplements, 18(3), 316-333.

• Maffei, M. E. (2020). 5-Hydroxytryptophan (5-HTP): Natural occurrence, analysis, biosynthesis, biotechnology, physiology and toxicology. International journal of molecular sciences, 22(1), 181.

• Shaw, K. A., Turner, J., & Del Mar, C. (2002). Tryptophan and 5‐Hydroxytryptophan for depression. Cochrane Database of Systematic Reviews, (1).

• Beckmann, H., Athen, D., Olteanu, M., & Zimmer, R. (1979). DL-phenylalanine versus imipramine: a double-blind controlled study. Archiv fuÈr Psychiatrie und Nervenkrankheiten, 227(1), 49-58.

• L-Tyrosin (2022). Kama Stress Management. https://www.kamastressmanagement.no/l-tyrosin

• Sabelli, H. C., Fawcett, J., Gusovsky, F., Javaid, J. I., Wynn, P., Edwards, J., ... & Kravitz, H. (1986). Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements. The Journal of clinical psychiatry, 47(2), 66-70.

• Daniela, J., Aikaterini, M., Miro, S., Yasushi, M., & Roman, D. (2005). Subchronic treatment with amino acid mixture of L-lysine and L-arginine modifies neuroendocrine activation during psychosocial stress in subjects with high trait anxiety. Nutritional neuroscience, 8(3), 155-160.

• Smriga, M., Ando, T., Akutsu, M., Furukawa, Y., Miwa, K., & Morinaga, Y. (2007). Oral treatment with L-lysine and L-arginine reduces anxiety and basal cortisol levels in healthy humans. Biomedical Research, 28(2), 85-90.

• Smriga, M., Ghosh, S., Mouneimne, Y., Pellett, P. L., & Scrimshaw, N. S. (2004). Lysine fortification reduces anxiety and lessens stress in family members in economically weak communities in Northwest Syria. Proceedings of the National Academy of Sciences, 101(22), 8285-8288.

• Marcon, M., Mocelin, R., de Oliveira, D. L., da Rosa Araujo, A. S., Herrmann, A. P., & Piato, A. (2019). Acetyl-L-carnitine as a putative candidate for the treatment of stress-related psychiatric disorders: Novel evidence from a zebrafish model. Neuropharmacology, 150, 145-152.

• Research Breakdown on L-Carnitine - Examine. (n.d.). Examine.com. Retrieved August 18, 2023, from https://examine.com/supplements/carnitine/research/#plqYNl6-interactions-with-fatigue

• Veronese, N., Stubbs, B., Solmi, M., Ajnakina, O., Carvalho, A. F., & Maggi, S. (2018). Acetyl-L-carnitine supplementation and the treatment of depressive symptoms: a systematic review and meta-analysis. Psychosomatic medicine, 80(2), 154-159.

• Zhang, J. J., Wu, Z. B., Cai, Y. J., Ke, B., Huang, Y. J., Qiu, C. P., ... & Qin, J. (2014). L-carnitine ameliorated fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome: a randomized controlled study. Nutrition journal, 13, 1-11.

• An, J. H., Kim, Y. J., Kim, K. J., Kim, S. H., Kim, N. H., Kim, H. Y., ... & Kim, S. G. (2016). L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment: a randomized, double-blind, placebo-controlled trial. Endocrine journal, 63(10), 885-895.

• Bilen, M., Ibrahim, P., Barmo, N., Abou Haidar, E., Karnib, N., El Hayek, L., ... & Sleiman, S. F. (2020). Methionine mediates resilience to chronic social defeat stress by epigenetic regulation of NMDA receptor subunit expression. Psychopharmacology, 237(10), 3007-3020.

• Islam, M., Ali, S., Karmoker, J. R., Kadir, M. F., Ahmed, M. U., Nahar, Z., ... & Hasnat, A. (2020). Evaluation of serum amino acids and non-enzymatic antioxidants in drug-naïve first-episode major depressive disorder. BMC psychiatry, 20(1), 1-8.

• Young, S. N., & Shalchi, M. (2005). The effect of methionine and S-adenosylmethionine on S-adenosylmethionine levels in the rat brain. Journal of Psychiatry and Neuroscience, 30(1), 44-48.

• Cuomo, A., Beccarini Crescenzi, B., Bolognesi, S., Goracci, A., Koukouna, D., Rossi, R., & Fagiolini, A. (2020). S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): a clinician-oriented systematic review. Annals of general psychiatry, 19(1), 1-7.

​

• Galizia, I., Oldani, L., Macritchie, K., Amari, E., Dougall, D., Jones, T. N., ... & Young, A. H. (2016). S‐adenosyl methionine (SAMe) for depression in adults. Cochrane Database of Systematic Reviews, (10).

• Bannai, M., Kawai, N., Ono, K., Nakahara, K., & Murakami, N. (2012). The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. Frontiers in neurology, 3, 61.

• Inagawa, K., Hiraoka, T., Kohda, T., Yamadera, W., & Takahashi, M. (2006). Subjective effects of glycine ingestion before bedtime on sleep quality. Sleep and Biological Rhythms, 4(1), 75-77.

• Yamadera, W., Inagawa, K., Chiba, S., Bannai, M., Takahashi, M., & Nakayama, K. (2007). Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep and Biological Rhythms, 5(2), 126-131.

• McMorris, T., Harris, R. C., Swain, J., Corbett, J., Collard, K., Dyson, R. J., ... & Draper, N. (2006). Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol. Psychopharmacology, 185(1), 93-103.

• Pazini, F. L., Cunha, M. P., & Rodrigues, A. L. S. (2019). The possible beneficial effects of creatine for the management of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 89, 193-206.

• Watanabe, A., Kato, N., & Kato, T. (2002). Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neuroscience research, 42(4), 279-285.

• Heresco-Levy, U., Vass, A., Bloch, B., Wolosker, H., Dumin, E., Balan, L., ... & Kremer, I. (2009). Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder. International Journal of Neuropsychopharmacology, 12(9), 1275-1282.

• Levin, R., Dor-Abarbanel, A. E., Edelman, S., Durrant, A. R., Hashimoto, K., Javitt, D. C., & Heresco-Levy, U. (2015). Behavioral and cognitive effects of the N-methyl-D-aspartate receptor co-agonist D-serine in healthy humans: initial findings. Journal of psychiatric research, 61, 188-195.

• MacKay, M. A. B., Kravtsenyuk, M., Thomas, R., Mitchell, N. D., Dursun, S. M., & Baker, G. B. (2019). D-Serine: potential therapeutic agent and/or biomarker in schizophrenia and depression?. Frontiers in psychiatry, 10, 25.

• Fernandes, B. S., Dean, O. M., Dodd, S., Malhi, G. S., & Berk, M. (2016). N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis. The Journal of clinical psychiatry, 77(4), 12403.

• Bradlow, R. C., Berk, M., Kalivas, P. W., Back, S. E., & Kanaan, R. A. (2022). The potential of N-Acetyl-L-Cysteine (NAC) in the treatment of psychiatric disorders. CNS drugs, 36(5), 451-482.

• Schwaiger, T. A. (2021). Review of the Use of N-Acetyl-Cysteine (NAC) in Clinical Practice. Nat. Med. J.

• Kumar, P., Liu, C., Hsu, J. W., Chacko, S., Minard, C., Jahoor, F., & Sekhar, R. V. (2021). Glycine and N‐acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: results of a pilot clinical trial. Clinical and translational medicine, 11(3), e372.

• Zalachoras, I., Hollis, F., Ramos-Fernández, E., Trovo, L., Sonnay, S., Geiser, E., ... & Morató, L. (2020). Therapeutic potential of glutathione-enhancers in stress-related psychopathologies. Neuroscience & Biobehavioral Reviews, 114, 134-155.

• Benjamin, J., Levine, J., Fux, M., Aviv, A., Levy, D., & Belmaker, R. H. (1995). Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. American Journal of Psychiatry, 152(7), 1084-1086.

• Mukai, T., Kishi, T., Matsuda, Y., & Iwata, N. (2014). A meta‐analysis of inositol for depression and anxiety disorders. Human Psychopharmacology: Clinical and Experimental, 29(1), 55-63.

• Palatnik, A., Frolov, K., Fux, M., & Benjamin, J. (2001). Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. Journal of clinical psychopharmacology, 21(3), 335-339.

• Barnish, M., Sheikh, M., & Scholey, A. (2023). Nutrient Therapy for the Improvement of Fatigue Symptoms. Nutrients, 15(9), 2154.

• Kim, M., Seol, J., Sato, T., Fukamizu, Y., Sakurai, T., & Okura, T. (2022). Effect of 12-week intake of nicotinamide mononucleotide on sleep quality, fatigue, and physical performance in older Japanese adults: a randomized, double-blind placebo-controlled study. Nutrients, 14(4), 755.

• Yi, L., Maier, A. B., Tao, R., Lin, Z., Vaidya, A., Pendse, S., ... & Kumbhar, V. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: A randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience, 45(1), 29-43.

• Dolopikou, C. F., Kourtzidis, I. A., Margaritelis, N. V., Vrabas, I. S., Koidou, I., Kyparos, A., ... & Nikolaidis, M. G. (2020). Acute nicotinamide riboside supplementation improves redox homeostasis and exercise performance in old individuals: a double-blind cross-over study. European journal of nutrition, 59, 505-515.

• Cao, W., Qiu, J., Cai, T., Yi, L., Benardot, D., & Zou, M. (2020). Effect of D-ribose supplementation on delayed onset muscle soreness induced by plyometric exercise in college students. Journal of the International Society of Sports Nutrition, 17, 1-9.

• Teitelbaum, J. E., Johnson, C., & Cyr, J. S. (2006). The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. Journal of Alternative & Complementary Medicine, 12(9), 857-862.

• Xue, Y., Shamp, T., Nagana Gowda, G. A., Crabtree, M., Bagchi, D., & Raftery, D. (2022). A combination of nicotinamide and D-ribose (RiaGev) is safe and effective to increase NAD+ metabolome in healthy middle-aged adults: a randomized, triple-blind, placebo-controlled, cross-over pilot clinical trial. Nutrients, 14(11), 2219.

• Bjelland, I., Tell, G. S., Vollset, S. E., Konstantinova, S., & Ueland, P. M. (2009). Choline in anxiety and depression: the Hordaland Health Study. The American journal of clinical nutrition, 90(4), 1056-1060.

• Harrison, K., Foster-Brown, C., Kelaiditis, C., Mavrommatis, Y., & Pilic, L. (2020). The associations between phosphatidylethanolamine N-methyltransferase gene, dietary choline intake and anxiety and depression in healthy UK adults. Proceedings of the Nutrition Society, 79(OCE3), E784.

• Li, J., Kang, X., Zhang, L., Luo, J., & Zhang, D. (2022). Dietary choline is inversely associated with depressive symptoms: A cross-sectional study of the National Health and Nutrition Examination Survey (NHANES) 2011 to 2018. Journal of Affective Disorders, 301, 23-29.

• Roohi-Azizi, M., Arabzadeh, S., Amidfar, M., Salimi, S., Zarindast, M. R., Talaei, A., & Akhondzadeh, S. (2017). Citicoline combination therapy for major depressive disorder: a randomized, double-blind, placebo-controlled trial. Clinical neuropharmacology, 40(1), 1-5.

• Jasielski, P., Piędel, F., Piwek, M., Rocka, A., Petit, V., & Rejdak, K. (2020). Application of citicoline in neurological disorders: a systematic review. Nutrients, 12(10), 3113.

• Cruse, J. L. (2018). The Acute Effects Of Alpha-Gpc On Hand Grip Strength, Jump Height, Power Output, Mood, And Reaction-Time In Recreationally Trained, College-Aged Individuals (Doctoral dissertation, Eastern Kentucky University).

• Kansakar, U., Trimarco, V., Mone, P., Varzideh, F., Lombardi, A., & Santulli, G. (2023). Choline supplements: An update. Frontiers in Endocrinology, 14, 1148166.

• Arazi, H., Aboutalebi, S., Taati, B., Cholewa, J. M., & Candow, D. G. (2022). Effects of short-term betaine supplementation on muscle endurance and indices of endocrine function following acute high-intensity resistance exercise in young athletes. Journal of the International Society of Sports Nutrition, 19(1), 1-16.

• Di Pierro, F., Orsi, R., & Settembre, R. (2015). Role of betaine in improving the antidepressant effect of S-adenosyl-methionine in patients with mild-to-moderate depression. Journal of multidisciplinary healthcare, 39-45.

• Bagheri, S., Haddadi, R., Saki, S., Kourosh-Arami, M., Rashno, M., Mojaver, A., & Komaki, A. (2023). Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article. Frontiers in Neuroscience, 17.

• Tsai, I. C., Hsu, C. W., Chang, C. H., Tseng, P. T., & Chang, K. V. (2022). Effectiveness of Coenzyme Q10 supplementation for reducing fatigue: a systematic review and meta-analysis of randomized controlled trials. Frontiers in pharmacology, 13, 883251.

• Zeng, Z., Li, Y., Lu, S., Huang, W., & Di, W. (2019). Efficacy of CoQ10 as supplementation for migraine: a meta‐analysis. Acta Neurologica Scandinavica, 139(3), 284-293.

• Glade, M. J., & Smith, K. (2015). Phosphatidylserine and the human brain. Nutrition, 31(6), 781-786.

• Hellhammer, J., Vogt, D., Franz, N., Freitas, U., & Rutenberg, D. (2014). A soy-based phosphatidylserine/phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: a randomized, placebo-controlled study. Lipids in health and disease, 13(1), 1-11.

• Akotkar, L., Aswar, U., Patil, R., Kumar, D., Aswar, M., Pandey, J., & Gurav, S. (2023). Antidepressant Effect of Alpha Lipoic Acid in Rats Exposed to Chronic Unpredictable Mild Stress: Putative Role of Neurotransmitters and 5HT3 Receptor. Future Pharmacology, 3(2), 407-425.

• Rezaei Kelishadi, M., Alavi Naeini, A., Askari, G., Khorvash, F., & Heidari, Z. (2021). The efficacy of alpha‐lipoic acid in improving oxidative, inflammatory, and mood status in women with episodic migraine in a randomised, double‐blind, placebo‐controlled clinical trial. International Journal of Clinical Practice, 75(9), e14455.

• Clayton, P., Subah, S., Venkatesh, R., Hill, M., & Bogoda, N. (2023). Palmitoylethanolamide: A potential alternative to cannabidiol. Journal of dietary supplements, 20(3), 505-530.

• Ghazizadeh-Hashemi, M., Ghajar, A., Shalbafan, M. R., Ghazizadeh-Hashemi, F., Afarideh, M., Malekpour, F., ... & Akhondzadeh, S. (2018). Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial. Journal of affective disorders, 232, 127-133.

• Lang-Illievich, K., Klivinyi, C., Lasser, C., Brenna, C. T., Szilagyi, I. S., & Bornemann-Cimenti, H. (2023). Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Nutrients, 15(6), 1350.

• Steels, E., Venkatesh, R., Steels, E., Vitetta, G., & Vitetta, L. (2019). A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis. Inflammopharmacology, 27, 475-485.

• Chao, L., Liu, C., Sutthawongwadee, S., Li, Y., Lv, W., Chen, W., ... & Guo, S. (2020). Effects of probiotics on depressive or anxiety variables in healthy participants under stress conditions or with a depressive or anxiety diagnosis: a meta-analysis of randomized controlled trials. Frontiers in Neurology, 11, 421.

• Liu, R. T., Walsh, R. F., & Sheehan, A. E. (2019). Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials. Neuroscience & Biobehavioral Reviews, 102, 13-23.

• McKean, J., Naug, H., Nikbakht, E., Amiet, B., & Colson, N. (2017). Probiotics and subclinical psychological symptoms in healthy participants: a systematic review and meta-analysis. The Journal of alternative and complementary medicine, 23(4), 249-258.

• Pirbaglou, M., Katz, J., de Souza, R. J., Stearns, J. C., Motamed, M., & Ritvo, P. (2016). Probiotic supplementation can positively affect anxiety and depressive symptoms: a systematic review of randomized controlled trials. Nutrition research, 36(9), 889-898.

• Smith, K. S., Greene, M. W., Babu, J. R., & Frugé, A. D. (2021). Psychobiotics as treatment for anxiety, depression, and related symptoms: a systematic review. Nutritional neuroscience, 24(12), 963-977.

• Tabrizi, A., Khalili, L., Homayouni-Rad, A., Pourjafar, H., Dehghan, P., & Ansari, F. (2019). Prebiotics, as Promising Functional Food to Patients with Psychological Disorders: A Review on Mood Disorders, Sleep, and Cognition. NeuroQuantology, 17(6).

• Taylor, A. M., & Holscher, H. D. (2020). A review of dietary and microbial connections to depression, anxiety, and stress. Nutritional neuroscience, 23(3), 237-250.

• Wallace, C. J., & Milev, R. (2017). The effects of probiotics on depressive symptoms in humans: a systematic review. Annals of general psychiatry, 16(1), 1-10.

• Aucoin, M., LaChance, L., Naidoo, U., Remy, D., Shekdar, T., Sayar, N., ... & Cooley, K. (2021). Diet and anxiety: A scoping review. Nutrients, 13(12), 4418.

• Ko, Y. H., Kim, S. K., Lee, S. Y., & Jang, C. G. (2020). Flavonoids as therapeutic candidates for emotional disorders such as anxiety and depression. Archives of Pharmacal Research, 43, 1128-1143.

• Monjotin, N., Amiot, M. J., Fleurentin, J., Morel, J. M., & Raynal, S. (2022). Clinical evidence of the benefits of phytonutrients in human healthcare. Nutrients, 14(9), 1712.

• Stringham, N. T., Holmes, P. V., & Stringham, J. M. (2018). Supplementation with macular carotenoids reduces psychological stress, serum cortisol, and sub-optimal symptoms of physical and emotional health in young adults. Nutritional Neuroscience, 21(4), 286-296.

• Wang, W., Liu, T., Ding, Y., & Zhang, Y. (2023). Effects of polyphenol-rich interventions on sleep disorders: A systematic review and meta-analysis. Current Research in Food Science, 100462.

• Yu, Q., Xue, F., Li, Z., Li, X., Ai, L., Jin, M., ... & Yu, Y. (2022). Dietary intake of carotenoids and risk of depressive symptoms: A systematic review and meta-analysis. Antioxidants, 11(11), 2205.

• Matias, J. N., Achete, G., Campanari, G. S. D. S., Guiguer, E. L., Araújo, A. C., Buglio, D. S., & Barbalho, S. M. (2021). A systematic review of the antidepressant effects of curcumin: Beyond monoamines theory. Australian & New Zealand Journal of Psychiatry, 55(5), 451-462.

• Abu-Izneid, T., Rauf, A., Khalil, A. A., Olatunde, A., Khalid, A., Alhumaydhi, F. A., ... & Rengasamy, K. R. (2022). Nutritional and health beneficial properties of saffron (Crocus sativus L): A comprehensive review. Critical Reviews in Food Science and Nutrition, 62(10), 2683-2706.

• Shafiee, M., Arekhi, S., Omranzadeh, A., & Sahebkar, A. (2018). Saffron in the treatment of depression, anxiety and other mental disorders: Current evidence and potential mechanisms of action. Journal of Affective Disorders, 227, 330-337.

• Ghazizadeh, J., Sadigh‐Eteghad, S., Marx, W., Fakhari, A., Hamedeyazdan, S., Torbati, M., ... & Mirghafourvand, M. (2021). The effects of lemon balm (Melissa officinalis L.) on depression and anxiety in clinical trials: A systematic review and meta‐analysis. Phytotherapy Research, 35(12), 6690-6705.

• Haybar, H., Javid, A. Z., Haghighizadeh, M. H., Valizadeh, E., Mohaghegh, S. M., & Mohammadzadeh, A. (2018). The effects of Melissa officinalis supplementation on depression, anxiety, stress, and sleep disorder in patients with chronic stable angina. Clinical nutrition ESPEN, 26, 47-52.

• Zam, W., Quispe, C., Sharifi-Rad, J., López, M. D., Schoebitz, M., Martorell, M., ... & Pezzani, R. (2022). An Updated Review on The Properties of Melissa officinalis L.: Not Exclusively Anti-anxiety. Frontiers in Bioscience-Scholar, 14(2), 16.

• Carroll, D., Ring, C., Suter, M., & Willemsen, G. (2000). The effects of an oral multivitamin combination with calcium, magnesium, and zinc on psychological well-being in healthy young male volunteers: a double-blind placebo-controlled trial. Psychopharmacology, 150(2), 220-225.

• Harris, E., Kirk, J., Rowsell, R., Vitetta, L., Sali, A., Scholey, A. B., & Pipingas, A. (2011). The effect of multivitamin supplementation on mood and stress in healthy older men. Human Psychopharmacology: Clinical and Experimental, 26(8), 560-567.

• Haskell, C. F., Robertson, B., Jones, E., Forster, J., Jones, R., Wilde, A., ... & Kennedy, D. O. (2010). Effects of a multi‐vitamin/mineral supplement on cognitive function and fatigue during extended multi‐tasking. Human Psychopharmacology: Clinical and Experimental, 25(6), 448-461.

• Long, S. J., & Benton, D. (2013). Effects of vitamin and mineral supplementation on stress, mild psychiatric symptoms, and mood in nonclinical samples: a meta-analysis. Psychosomatic medicine, 75(2), 144-153.

• Sarris, J., Mehta, B., Óvári, V., & Giménez, F. (2021). Potential mental and physical benefits of supplementation with a high-dose, B-complex multivitamin/mineral supplement: What is the evidence?. Nutricion Hospitalaria.

• Schlebusch, L., Bosch, B. A., Polglase, G., Kleinschmidt, I., Pillay, B. J., & Cassimjee, M. H. (2000). A double-blind, placebo-controlled, double-centre study of the effects of an oral multivitamin-mineral combination on stress. S Afr Med J, 90(12), 1216-1223.